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2Abstract
Our previously presented method for high through-
put computational screening of mutant activity
(Hediger et al., http://arxiv.org/abs/1203.2950)
is benchmarked against experimentally measured
amidase activity for 22 mutants of Candida antarc-
tica lipase B (CalB). Using an appropriate cutoff
criterion for the computed barriers, the qualitative
activity of 15 out of 22 mutants is correctly pre-
dicted. The method identifies four of the six most
active mutants with ≥3-fold wild type activity and
seven out of the eight least active mutants with
≤0.5-fold wild type activity. The method is further
used to screen all sterically possible (386) double-,
triple- and quadruple-mutants constructed from the
most active single mutants. Based on the bench-
mark test at least 20 new promising mutants are
identified.
Introduction
In industry, one frequently tries to modify an en-
zyme in order to enhance its functionality in a cer-
tain way [1–5]. From an application point of view,
one of the most interesting questions is how to mod-
ify an enzyme such that its activity is enhanced
compared to wild type or such that a new kind
of activity is introduced into the enzyme [6]. It
can therefore be of considerable relevance to have a
method available which efficiently allows to a pri-
ori discriminate between promising candidates for
experimental study and mutants which can be ex-
cluded from the study.
Numerous methods are currently being proposed
and developed for the description of enzyme activ-
ities, the theoretical background of which ranges
from phenomenological approaches [7–10] to quan-
tum mechanics based ab initio descriptions [11–19].
However one can expect that methods which are
highly demanding in terms of set-up efforts and
computational time are less likely to be employed
in industrial contexts where qualitative or semi-
quantitative conclusions can be of sufficient use
in the beginning and planning phase of a wet-lab
study. Few approaches, while taking into account
a number of approximations and limitations in ac-
curacy, aim at being used in parallel or prior to
experimental work [20, 21] and are not designed to
be used for high throughput fashion.
Hediger et al. have recently published a computa-
tional method for high throughput computational
screening of mutant activity [22] and in this paper
we benchmark the method against experimentally
measured amidase activity for mutants of Candida
antarctica lipase B (CalB) and apply the method
to identify additional promising mutants.
Methods
We introduce the experimental set-up and the
methodology for comparing experimental and com-
putational data. We describe a benchmarking and
a combinatorial study of CalB mutant activity.
Experimentally, variants of Candida Antarctica li-
pase B (CalB) were either produced in Pichia pas-
toris with C-terminal His6-tag for subsequent affin-
ity purification or expressed in Aspergillus oryzae
without terminal tag followed by a three-step pu-
rification procedure.
It is generally accepted that in serine protease like
enzymes, the formation of the tetrahedral interme-
diate (TI, Fig. 1) is rate determining [23–26] and
throughout this work we assume that a lower bar-
rier for this reaction correlates to increased overall
activity of the enzyme.
The substrate used throughout this study is N-
benzyl-2-chloroacetamide. The organisms used for
expression of the individual variants are indicated
in Table 1.
Generation of CalB Variants without His-
tags
Variants of CalB carrying the CalB signal pep-
tide were generated at the DNA level using
QuickChange mutagenesis on the corresponding
gene residing in a dual E.coli/Aspergillus Pichia
pastoris expression vector. The PCR was per-
formed with proofreading DNA polymerase (New
England Biolabs, NEB). To remove parent tem-
plates, they were methylated in vitro prior to PCR
with CpG methyltransferase (from NEB) and di-
gested in vivo after transformation of competent
E.coli DH5 α cells (TaKaRa) according to the in-
structions from the manufacturer. Plasmid DNA
3was isolated from transformed E.coli strains, and
sequenced to verify the presence of the desired sub-
stitutions. Confirmed plasmid variants were used to
transform an Aspergillus oryzae strain that is neg-
ative in pyrG (orotidine-5’-phosphate decarboxy-
lase), proteases pepC (aserine protease homologous
to yscB), alp (an alkaline protease) NpI (a neutral
metalloprotease I) to avoid degradation of the li-
pase variants during and after fermentation.
The transformed Aspergillus strains were fermented
as submerged culture in shake flasks and the lipase
variants secreted into the fermentation medium.
After the fermentation, the lipase variants were pu-
rified from the sterile filtered fermentation medium
in a 3 step procedure with 1) hydrophobic inter-
action chromatography on decylamine-agarose, 2)
buffer exchange by gel filtration and 3) ion ex-
change chromatography with cation exchange on
SP-sepharose at pH 4.5. The lipase variant solu-
tions were stored frozen.
Generation of CalB Variants with His-tags
Variants of CalB carrying the CalB signal pep-
tide and C-terminal His-tags were generated at the
DNA level using SOE-PCR and inserted into a dual
E.coli/Pichia pastoris expression vector using In-
fusion cloning (ClonTech). The SOE-PCR was per-
formed with Phusion DNA polymerase (NEB) and
template DNA of the CalB gene. The cloned plas-
mids were transformed in competent E.coli DH5 α
cells (TaKaRa). Plasmid DNA was isolated from
transformed E.coli strains, and sequenced to ver-
ify the presence of the desired substitutions. Con-
firmed plasmid variants were used to transform a
Pichia pastoris strain that is Mut(s), Suc(+), His(-
). The transformed Pichia strains were fermented
as submerged culture in deep well plates and se-
cretion of the lipase variants into the fermentation
medium was induced by addition of methanol. Af-
ter the fermentation, the lipase variants were puri-
fied from the cleared supernants using a standard
His-tag purification protocol (Qiagen) and buffer-
exhanged into 50 mM phosphate buffer, pH 7.0, us-
ing Amicon Ultra centrifugal filter devices with a
10 kDa cutoff (Merck Millipore).
Activity Measurement
Amidase activity of CalB variants was determined
in a two-step fluorimetric assay previously described
by Henke et al [27]. First, enzymatic hydroly-
sis of N-benzyl-2-chloroacetamide was performed
in 96-well microtiter plates in 200 µL phosphate-
buffered aqueous solution pH 7.0 including 10% or-
ganic co-solvent (THF or DMSO). Reactions con-
taining 5 mM amide substrate, 0.3-3 µM enzyme,
and 12 µg/mL BSA were incubated for 18-20 h at
37◦C in a shaker incubator. In a second step, 50 µL
of a 20 mM 4-nitro-7-chloro-benzo-2-oxa-1,3-diazole
(NBD-Cl) solution in 1-hexanol was added and the
reaction of NBD-Cl with benzylamine formed dur-
ing amide hydrolysis proceeded under identical re-
action conditions for another hour.
Fluorescence of the final reaction product was de-
termined with excitation at 485 nm and measured
emission at 538 nm. Calibration of the amide hy-
drolysis reaction was performed on each assay plate
with benzylamine covering a concentration range
between 0.05 and 5 mM. All enzymatic activities
were corrected for non-enzymatic background reac-
tion determined under identical conditions without
enzyme present.
Compuational Details
The computational method used to estimate the re-
action barriers of the CalB mutants has been de-
scribed in detail earlier [22] and is only summarized
here.
The reaction barriers are estimated computation-
ally by preparing molecular model structures [22]
(consisting of around 840 atoms) of the enzyme sub-
strate complex (ES) and the tetrahedral interme-
diate (TI) inbetween which linear interpolation is
carried out to generate structures of the enzyme
on the reaction path. The geometry of each inter-
polation frame is optimized while keeping the dis-
tance between the nucleophilic carbon C20 of the
substrate and Oγ of serine 105 (Fig. 1) fixed at a
specific value di = dini − i(dini − dfin)/10, where
dini and dfin are the distances between C
20 and Oγ
in the ES complex and TI, respectively (in A˚, 10
being the number of interpolation frames and i the
interpolation frame index). In geometry optimiza-
tion calculations, the gradient convergence criteria
is set to 0.5 kcal/(molA˚) and a linear scaling im-
plementation of the PM6 method (MOZYME [28])
together with a NDDO cutoff of 15 A˚ is applied.
The energy profile of the reaction barrier at the
PM6 level of theory [29] is subsequently mapped
out by carrying out conventional SCF calculations
of each optimized interpolation frame. All calcula-
4tions are carried out using the MOPAC suite of pro-
grams [30, 31]. The molecular models are based on
the crystal structure of the CalB enzyme with PDB
identifier 1LBS [32]. In order to prevent significant
rearrangement of hydrogen bonding network of sur-
face residues during the optimization, a number of
additional structural constraints are applied in the
geometry optimizations, i.e. the residues S50, P133,
Q156, L277 and P280 are kept fixed. These (sur-
face) residues are observed to rearrange and form
new hydrogen bonds in optimizations when no con-
straints are applied. Omitting the constraints leads
to unconclusive barrier shapes containing many ir-
regular minima along the reaction coordinate which
do not permit to readily define a reaction barrier.
For the analysis, the reaction barrier is defined by
the difference between the highest energy point on
the reaction profile and the energy corresponding
to the enzyme substrate complex. From our calcu-
lations (PM6//MOZYME in vacuum), we estimate
the wild type (WT) barrier to be 7.5 kcal/mol.
Experimentally, specific activity of hydrolysis is de-
termined. Given first order kinetics, saturation of
the enzyme with substrate and fast binding and
product release, the catalytic rate constant kcat is
directly proportional to the specific activity under
the assumption that the amount of active enzyme
remains constant. This therefore allows the cat-
alytic rate constant kcat and, hence, the barrier
height to be compared to the improvement factors
reported in the results section. The approximations
used here in relating the barrier height on the po-
tential energy surface to kcat have been discussed
previously [22].
It is noted that using one CPU per interpolation
frame on the reaction barrier, the complete barrier
of one mutant can be computed with 10 CPUs usu-
ally within less than 12 hours of wall clock time (for
a molecular model of the size used in this study).
Given a set of molecular models of the enzyme, and
100 available CPUs, it is possible to screen around
1000 mutants within one week.
Combination Mutants
The molecular model of the enzyme and the posi-
tions of the point mutations in the enzyme are illus-
trated in Fig. 2. The point mutations are listed in
Table 2. Two sets of mutants are introduced in this
section. A benchmarking set S and a combinatorial
set L, the definitions of which are provided in the
following.
The point mutations are selected based on differ-
ent design principles. These are either introduction
of structural rearrangements in the active site to
change the binding site properties of the active site
(residues P38, G39, G41 T42 T103) [1], introduc-
tion of space to accomodate the substrate (W104,
L278, A282, I285, V286), introduction of dipolar
interactions between the enzyme and the substrate
(A132, A141, I189) [33] or reduction of polarity in
the active site (D223). The mutants of the bench-
marking study are collected in a small set S (22 mu-
tants, Table 1). For the combinatorial study, out of
the above we select six residues (G39, T103, W104,
A141, I189, L278) which, it is assumed, contribute
strongest to increased activity and define the mu-
tations at each position as listed in Table 3. Given
the position i and the number of mutations at each
position gi, in general the upper limit for the num-
ber of mutants M in a combinatorial study can be
calculated by writing a sum term for each type (i.e.
“order”) of combination mutant, i.e. single, dou-
ble, . . . , such that
M =
∑
i
gi
︸ ︷︷ ︸
Single
(o=1)
+
∑
i,j
j>i
gi · gj
︸ ︷︷ ︸
Double
(o=2)
+
∑
i,j,k
k>j>i
gi · gj · gk
︸ ︷︷ ︸
Triple
(o=3)
+ . . .
(1)
where each sum term consists of
(
N
o
)
individual
terms (N and o being the number of positions which
can be mutated and the order of the mutant, re-
spectively). By this scheme, considering the mu-
tations listed in Table 3, hypothetically 424 (= 13
+ 64 + 154 + 193) single to four-fold mutants can
be constructed. This number is reduced by apply-
ing the restriction that out of the 424 hypotheti-
cally possible mutants, 0 single, 2 double, 12 triple
and 24 four-fold combination mutants including the
pair A141N/Q-I189Y are discarded because in the
molecular modeling, these side chains could not be
allocated spatially in the same mutant. We further
note that 15 out of these remaining 386 mutants
(Table 3) are present also in the benchmarking set
S and thus the combinatorial study consists of 371
unique mutants. A detailed documentation of the
number of screened residues in the combinatorial
study is provided in Table 4.
Prior to analysis, the reaction barriers of the com-
5bination mutants are inspected visually and mu-
tants with irregularly shaped barriers, i.e. con-
sisting of multiple peaks of similar height along
the reaction coordinate, are discarded. Further-
more, out of the mutants with regular reaction bar-
rier shapes, we discard those mutants with barriers
>19.0 kcal/mol (i.e. the largest calculated barrier
from set S). Following these selection criteria, 61
mutants are discarded because of inconclusive bar-
rier shapes and 47 mutants because the barrier is
higher than 19 kcal/mol (a distribution of reaction
barriers is shown in Fig. S1). After these filter-
ing steps, 278 mutants remain in the combinatorial
study which we collect in the large set L (out of
which 15 are in set S). An overview on the distri-
bution of reaction barriers for the mutants from set
L is provided Fig. S2 of the supporting informa-
tion.
We note that in set S, all barriers appear regular
in shape and no mutant contains the A141N/Q and
I189Y pair.
Results and Discussion
Set S
The correspondance of the computed barriers from
set S with the experimental assay is shown in Fig.
3. The exact data is reported in Table 1. A scat-
terplot of calculated reaction barriers is presented
in Fig. 4.
We note that in set S, the highest experimen-
tally observed activity is around 11 times the wild
type activity (G39A-T103G-W104F-L278A, Table
1), while roughly ten mutants show no increased
activity. In total, six mutants show 3-fold or higher
wild type activity. In the calculations, only one
mutant is observed to have a lower barrier than
the wild type (7.3 kcal/mol, G39A-T103G-L278A)
and the highest observed barrier is 18.9 kcal/mol
(I189G).
Given the approximations introduced to make the
method sufficiently efficient, it is noted that the in-
tent of the method is not a quantitative ranking of
the reaction barriers, but to identify promising mu-
tants for, and to eliminate non-promising mutants
from, experimental consideration. Therefore only
qualitative changes in overall activity are consid-
ered.
We categorize the experimentally observed activi-
ties and the predicted reaction barriers as follows.
From experiment, a mutant with activity of 1.2
(0.8) times the wild type activity or higher (lower) is
considered as improving (degrading). Correspond-
ingly, the computed difference in reaction barrier
height between a mutant and the wild type is ex-
pressed in qualitative terms. For the comparison
with the experimental activity assay, we define a
barrier cutoff cS = 12.5 kcal/mol to distinguish be-
tween potentially improving and degrading mutants
in set S.
A mutant with a predicted barrier ≥cS (12.5
kcal/mol) is considered to likely have decreased ac-
tivity compared to the wild type while mutants with
reaction barriers <cS are considered likely having
increased activity.
We note that defining the cutoff is done purely for
a post hoc comparison of experimental and com-
puted data. When using the computed barriers to
identify promising experimental mutants, one sim-
ply chooses the N mutants with the lowest barriers,
where N is the number of mutants affordable to do
experimentally (e.g. 20 in the discussion of set L).
Based on this approach, qualitative activity of 15
out of 22 mutants is correctly predicted. It is noted
that the correlation is best for mutants with largest
activity difference compared to wild type (both pos-
itive or negative). For example the method identi-
fies four of the six most active mutants with ≥3-fold
wild type activity. Similarly, the method identi-
fies seven out of the eight least active mutants with
≤0.5-fold wild type activity. For mutants with only
small differences in activity compared to wild type,
the predictions are less accurate.
Set L
Set L is screened to identify new mutants for
which increased activity is predicted. The 20
mutants with the lowest barriers are suggested as
candidates for further experimental study in Table
5. The distributions of reaction barriers, resolved
by mutations at positions 104 and 189, are shown
in Figs. 5A and B.
In set L, three new mutants are identified with
barriers lower than the predicted wild type barrier.
Out of the 20 mutants suggested in Table 5, three
are double mutants, seven are three-fold and ten
are four-fold mutants. No single mutants where
found for which increased activity compared to
6wild type is predicted. All mutants except one con-
tain the G39A mutation, five contain the T103G
mutation, six contain a mutation of W104, 13
contain a mutation of A141, 16 contain a mutation
of I189 and eight contain the L278A mutation.
From this observation it is likely that mutations
of G39, A141 and I189 will likely contribute to an
increased activity of the mutant and should thus
be included in future experimental activity assays.
Set L is further analysed in terms of the effect of
the mutations at the positions 104 and 189. For the
mutations of W104, we note that single mutations
which give rise to relatively high barriers (W104Q,
W104Y, Fig. 5A) can have significantly lower
barriers in combination with other mutations. For
example, out of the sixty mutants with lowest
barriers (Fig. S3), 33 contain a mutation of W104
out of which 17 are suggested to be W104F,
while 14 are suggested to be W104Y (two contain
W104Q).
The mutation of I189 is analysed in a similar way.
In set L, five different mutations of this residue are
screened (Table 3). The single mutant with the
lowest barrier is I189Y and the two mutants with
the lowest predicted barrier contain this mutation
as well (Table 5). Similarly to above, higher order
mutants containing I189A, I189G, I189H or I189N
are predicted to have considerably lower barriers
than the corresponding single mutants, Fig. 5B.
Particularly, out of the mutants listed in Table
5, three contain the I189A, one contains I189G
mutation, four contain the I189H mutation and
three contain the I189N mutation.
As a special case we highlight that the single
mutant I189G has one of the highest calculated
barriers (18.9 kcal/mol, Table 1), however the
four-fold mutant G39A-A141Q-I189G-L278A has
one of the lowest barriers (6.3 kcal/mol, Table
5). Interestingly, the mutant G39A-A141Q-L278A
has an intermediate barrier (10.9 kcal/mol). It
would appear that I189G as a single mutant is
counterproductive (high computed barrier) but
lowers the barrier of G39A-A141Q-L278A.
Observations as these should be kept in mind when
selecting the single mutants to be considered when
preparing higher order mutants.
Conclusions
Our previously presented method for high through-
put computational screening of mutant activity [22]
is benchmarked against experimentally measured
amidase activity for 22 mutants of Candida antarc-
tica lipase B (CalB).
Experimentally, amidase activity is successfully in-
troduced in 12 mutants, the highest activity is de-
termined to be 11.2 -fold over the wild type activity.
Using an appropriate cutoff criterion for the com-
puted barriers, the qualitative activity of 15 out of
22 mutants is correctly predicted. It is noted that
the correlation is best for mutants with largest ac-
tivity difference compared to wild type (both posi-
tive and negative). For example the method identi-
fies four of the six most active mutants with ≥3-fold
wild type activity. Similarly, the method identi-
fies seven out of the eight least active mutants with
≤0.5-fold wild type activity.
Thus validated, the computational method is used
to screen all sterically possible (386) double-, triple-
and quadrupole-mutants constructed from the most
active single mutants. Based on the benchmark test
at least 20 new promising mutants are identified.
Interestingly, we observe that single mutants that
are predicted to have low activity appear to have
high activity in combination with other mutants.
This is illustrated in specific analysis of effects of
mutations of two different positions (104 and 189).
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Figure 1. Reaction scheme for the formation of TI. Nucleophilic attack by Oγ of S105 on
carbonyl carbon C20 of substrate. R1: -CH2-Cl, R2: -CH2-C5H6.
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Figure 3. Comparison of experimental and computed activities. 1/-1 correspond to
increased/decreased overall activity, respectively. Prediction rate is 15/22 (68%).
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Figure 4. Barrier scatter plot of set S. 22 mutants; The cutoff value cS is discussed in the text.
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Figure 5. Barrier scatter plots of set L. In both panels, the labels indicate mutants containing the
labeled and possibly additional mutations up to the indicated order. “OTHER” indicates a mutant not
containing any of the labeled mutations or of higher than 4. order. A: Mutations of W104. B:
Mutations of I189.
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Tables
Table 1. Experimental overall activities and calculated reaction barriers of Set S. Category
(Cat.) +1/-1 indicates increased/decreased overall activity. Category definition is discussed in text. Ao
and Pp indicating expression in organisms (Org.) Aspergillus oryzae or Pichia pastoris, respectively.
Species Exp.
Activity
[*WT]
Cat. Calc.
Barriers
[kcal/mol]
Cat. Org.
G39A-T103G-W104F-L278A 11.2 1 13.9 -1 Ao
G39A-L278A 7.0 1 11.3 1 Pp
G39A-W104F 4.2 1 10.6 1 Ao
G39A-T103G-L278A 3.8 1 7.3 1 Ao
G39A-W104F-L278A 3.6 1 11.8 1 Pp
T103G 3.0 1 13.6 -1 Ao
G39A-W104F-I189Y-L278A 2.9 1 10.9 1 Pp
G39A 2.8 1 11.2 1 Ao
L278A 2.5 1 12.8 -1 Ao
W104F 2.0 1 12.0 1 Ao
G39A-T103G-W104Q-L278A 1.9 1 12.8 -1 Ao
G39A-T103G-W104F-D223G-L278A 1.5 1 11.3 1 Pp
G39A-T103G 0.8 -1 7.5 1 Ao
G39A-T42A-T103G-W104F-L278A 0.7 -1 10.4 1 Pp
I189H 0.5 -1 12.9 -1 Pp
G39A-I189G-L278A 0.4 -1 10.7 1 Pp
G41S 0.3 -1 13.4 -1 Pp
I189G 0.2 -1 18.9 -1 Pp
G39A-T103G-W104F-I189H-D223G-L278A 0.1 -1 13.7 -1 Pp
G39A-T103G-W104F-I189H-L278A-A282G-I285A-V286A 0.1 -1 12.9 -1 Pp
A132N 0.0 -1 12.5 -1 Pp
P38H 0.0 -1 12.5 -1 Pp
WT 1.0 -- 7.5 --
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Table 2. Point mutations. The term active site refers to residues with potential direct Van der
Waals contact to the substrate. The term first shell/second shell refers to residues which are adjecent
to an active site/first shell residue.
Target Mutations Type Description
P38 H Second shell (H neutral)
G39 A First shell
G41 S First shell
T42 A Second shell
T103 G First shell
W104 F, Q, Y Active site
A132 N First shell
A141 N, Q Active site
I189 A, G, H, N, Y Active site (G including additional water,
H neutral)
D223 G First shell (Increase of charge by +1)
L278 A Active site
A282 G Active site
I285 A Active site
V286 A First shell
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Table 3. Side chains used for generation of combinatorial set L. i and gi indicate the position
in the back bone and the number of mutations at that position, respectively.
Mutation i gi
G39A 39 1
T103G 103 1
W104{F, Q, Y} 104 3
A141{N, Q} 141 2
I189{A, G, H, N, Y} 189 5
L278A 278 1
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Table 4. Combinatorial study details. From the possible mutants, the combinations containing the
pair A141N/Q-I189Y, the mutants with inconclusive barriers and the mutants with barriers
>19.0 kcal/mol are subtracted to give the number of mutants in set L. “Only Set L” indicates the
number of mutants uniquely present in set L and not in set S.
Order Possible Containing Inconclusive Barrier >19.0 Set L Only
A141N/Q-I189Y barrier [kcal/mol] Set L
Single 13 0 0 0 13 7
Double 64 2 4 8 50 47
Triple 154 12 21 20 101 98
Four-fold 193 24 36 19 114 111
Total 424 38 61 47 278 263
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Table 5. Selection of mutants from set L with lowest barriers.
Mutation Barrier[kcal/mol]
G39A-T103G-I189Y 5.7
G39A-I189Y 6.2
G39A-A141Q-I189G-L278A 6.3
G39A-A141N-L278A 7.6
G39A-A141N 7.7
G39A-A141N-I189H-L278A 8.3
G39A-W104F-A141Q-I189A 8.3
G39A-A141Q-I189N 9.1
G39A-A141N-I189N 9.3
G39A-T103G-W104Y-A141N 9.8
G39A-W104Y-I189Y 9.8
G39A-A141N-I189N-L278A 10.1
G39A-W104F-A141N 10.1
G39A-I189H-L278A 10.2
G39A-A141N-I189A-L278A 10.2
W104Y-I189H 10.4
G39A-T103G-W104F-I189Y 10.4
G39A-A141Q-I189A-L278A 10.4
G39A-T103G-A141Q-I189H 10.4
G39A-T103G-I189A-L278A 10.5
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Figure S1. Discarded mutants with barriers > 19.0 kcal/mol. Single mutants: 0; Double
mutants: 8; Triple mutants: 20; Four-fold mutants: 19; Total: 47.
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Figure S2. Combination mutants from set L. Single: 13; Double mutants: 50; Triple mutants:
101; Four-fold mutants: 114: Total: 278.
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Figure S3. Low-barrier mutants. 33 out of 60 contain a mutation of W104 (W104F: 17, W104Y:
14, W104Q: 2).
